Source-grounded facts extracted from EXELON CORP's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
EXELON CORP reported the first quarter of 2026 results: EPS $0.90 per share. Guidance reaffirmed.
“EXELON REPORTS FIRST QUARTER 2026 RESULTS Earnings Release Highlights • GAAP net income of $0.90 per share and Adjusted (non-GAAP) operating earnings of $0.91 per share for the first quarter of 2026 • Affirming full year 2026 Adjusted (non-GAAP) operating earnings guidance range of $2.81-$2.91 per share”
EXELON CORP incurred senior notes of $775 million with The Bank of New York Mellon Trust Company, N.A. at 4.950% per annum maturing March 15, 2036.
“On February 20, the Company issued and sold $775 million in aggregate principal amount of the Notes.”
EXELON CORP entered into 4.950% Notes due 2036 valued at $775 million (effective 2026-02-20).
“On February 20, 2026, Exelon Corporation (the “Company”) issued and sold $775 million in aggregate principal amount of its 4.950% Notes due 2036 (the “Notes”).”
EXELON CORP incurred convertible notes of $1 billion aggregate principal amount with The Bank of New York Mellon Trust Company, N.A. (trustee) at 3.25% per year maturing March 15, 2029.
“On December 4, 2025, Exelon Corporation (the “Company”) completed its previously announced sale of $1 billion aggregate principal amount of 3.25% Convertible Senior Notes due 2029 (the “Notes”), which amount includes the exercise in full of the $100 million option to purchase additional Notes granted to the initial purchasers, in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).”
David DeWalt was appointed as independent director at EXELON CORP.
“On March 10, 2025, the Board of Directors ("Board") of Exelon Corporation (“Exelon”) appointed David DeWalt as an independent director of Exelon, effective immediately.”
EXELON CORP shareholders rejected Shareholder proposal to adopt a shareholder right to call a special shareholder meeting at the 2024-04-30 meeting.
“The shareholder proposal to adopt a shareholder right to call a special shareholder meeting was not approved based upon the following votes: FOR %FOR AGAINST ABSTAIN BROKER NON-VOTE 272,694,031 33.97% 529,901,740 6,057,097 75,846,299”
EXELON CORP shareholders approved Amendment to Articles of Incorporation to allow shareholders owning at least 25% to call a special meeting at the 2024-04-30 meeting.
“The proposal to approve an amendment to Exelon's Articles of Incorporation to allow shareholders owning at least 25% of Exelon's stock to call a special meeting was approved based upon the following votes: FOR %FOR AGAINST ABSTAIN BROKER NON-VOTE 798,867,295 99.03% 7,818,789 1,966,784 75,846,299”
EXELON CORP shareholders approved Advisory vote on executive compensation at the 2024-04-30 meeting.
“The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers was approved based upon the following votes: FOR %FOR AGAINST ABSTAIN BROKER NON-VOTE 744,873,039 93.68% 50,200,009 13,579,820 75,846,299”
EXELON CORP shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent auditor for 2024 at the 2024-04-30 meeting.
“The proposal to ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent auditor for 2024 was approved based upon the following votes: FOR %FOR AGAINST ABSTAIN BROKER NON-VOTE 828,314,197 93.76% 55,045,868 1,139,102 N/A”
EXELON CORP shareholders approved Election of Directors at the 2024-04-30 meeting.
“Each of the nominees for election to the Board of Directors were elected based on the following votes: DIRECTOR FOR %FOR AGAINST ABSTAIN BROKER NON-VOTE Paul Bowers 794,504,143 98.41% 12,817,845 1,330,880 75,846,299 Calvin G. Butler, Jr. 803,622,858 99.57% 3,435,698 1,594,312 75,846,299 Marjorie Rodgers Cheshire 798,911,179 98.97% 8,285,273 1,456,416 75,846,299 Linda Jojo 799,857,583 99.08% 7,420,755 1,374,530 75,846,299 Charisse Lillie 802,554,461 99.41% 4,685,807 1,412,600 75,846,299 Anna Richo 803,445,704 99.55% 3,613,893 1,593,271 75,846,299 Matthew Rogers 804,154,216 99.60% 3,182,169 1,316,483 75,846,299 Bryan Segedi 804,201,563 99.63% 2,967,168 1,484,137 75,846,299 John Young 761,139,046 94.28% 46,119,108 1,394,714 75,846,299”
EXELON CORP reported first quarter of 2024 results: net income $0.66 per share, EPS $0.66 per share. Guidance reaffirmed.
“Exelon's GAAP Net Income for the first quarter of 2024 decreased to $0.66 per share from $0.67 per share in the first quarter of 2023.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.